Overview of the study investigating gut healing in short bowel syndrome using GLP-2 therapy. (IMAGE)

Keio University Global Research Institute

Overview of the study investigating gut healing in short bowel syndrome using GLP-2 therapy.

Caption

This infographic summarizes the main aspects of this longitudinal study—the first study to analyze the changes caused by glucagon-like peptide-2 (GLP-2) analogs to the intestinal environment in patients with SBS over a one-year period of treatment.

Credit

Dr. Yumi Kudo from Keio University, Japan

Usage Restrictions

Cannot be reused without permission

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.